Lunai Bioworks Inc

Research Lunai Bioworks Inc (LNAI) on Bullrun: market cap USD 14.37M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerLNAI
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 14.37M
• Financial periodFY2025
• Net income-USD 178.01M

Valuation Snapshot

latest market cap is USD 14.37M.

About Lunai Bioworks Inc

Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer.

Frequently asked questions

What is Lunai Bioworks Inc's market cap?

Lunai Bioworks Inc's market capitalization is USD 14.37M.

What does Lunai Bioworks Inc do?

Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC.